Skip to main content
. 2022 Jan 26;14:327–337. doi: 10.2147/CMAR.S330368

Figure 4.

Figure 4

Exosomal lncRNA ATB derived from ovarian cancer cells promotes the migration of HUVECs. HUVECs were treated with ovarian cancer cells-derived exosomes with or without lncRNA ATB siRNA for 24 h. (A and B) Transwell and wound healing assays were performed to detect the migration of HUVECs. **P < 0.01; n = 3.